JP2022535850A - ピラゾール化合物の非吸湿性結晶塩、ならびにその医薬組成物および使用 - Google Patents

ピラゾール化合物の非吸湿性結晶塩、ならびにその医薬組成物および使用 Download PDF

Info

Publication number
JP2022535850A
JP2022535850A JP2021571903A JP2021571903A JP2022535850A JP 2022535850 A JP2022535850 A JP 2022535850A JP 2021571903 A JP2021571903 A JP 2021571903A JP 2021571903 A JP2021571903 A JP 2021571903A JP 2022535850 A JP2022535850 A JP 2022535850A
Authority
JP
Japan
Prior art keywords
crystalline salt
hygroscopic crystalline
acid
salt
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021571903A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020247345A5 (https=
JP2022535850A5 (https=
Inventor
ロバート サリバン，
Original Assignee
バイオセリックス， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオセリックス， インコーポレイテッド filed Critical バイオセリックス， インコーポレイテッド
Publication of JP2022535850A publication Critical patent/JP2022535850A/ja
Publication of JPWO2020247345A5 publication Critical patent/JPWO2020247345A5/ja
Publication of JP2022535850A5 publication Critical patent/JP2022535850A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2021571903A 2019-06-03 2020-06-02 ピラゾール化合物の非吸湿性結晶塩、ならびにその医薬組成物および使用 Pending JP2022535850A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962856605P 2019-06-03 2019-06-03
US62/856,605 2019-06-03
PCT/US2020/035654 WO2020247345A1 (en) 2019-06-03 2020-06-02 Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof

Publications (3)

Publication Number Publication Date
JP2022535850A true JP2022535850A (ja) 2022-08-10
JPWO2020247345A5 JPWO2020247345A5 (https=) 2023-06-09
JP2022535850A5 JP2022535850A5 (https=) 2023-06-09

Family

ID=71787173

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021571903A Pending JP2022535850A (ja) 2019-06-03 2020-06-02 ピラゾール化合物の非吸湿性結晶塩、ならびにその医薬組成物および使用

Country Status (13)

Country Link
US (1) US12428399B2 (https=)
EP (1) EP3976600A1 (https=)
JP (1) JP2022535850A (https=)
KR (1) KR20220041050A (https=)
CN (1) CN114423752B (https=)
AU (1) AU2020288163B2 (https=)
BR (1) BR112021024330A2 (https=)
CA (1) CA3142271A1 (https=)
IL (1) IL288547B2 (https=)
MX (1) MX2021014842A (https=)
SG (1) SG11202113211PA (https=)
TW (1) TWI866977B (https=)
WO (1) WO2020247345A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230047732A1 (en) * 2020-01-13 2023-02-16 Biotheryx, Inc. Pyrazolylpyrimidines and use thereof
WO2022204220A1 (en) * 2021-03-24 2022-09-29 Biotheryx, Inc. Pyrazolylpyrimidines for treating malignant solid tumor
US20230053307A1 (en) * 2021-07-19 2023-02-16 Buddhist Tzu Chi Medical Foundation Method for preventing or treating skin disorders and conditions
WO2025199440A1 (en) * 2024-03-21 2025-09-25 Edgewood Oncology Methods of treating liposarcoma using a pyrazole compound

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502425A (ja) * 1999-06-22 2003-01-21 ファイザー・プロダクツ・インク Ｎｋ−１受容体アンタゴニストとしての（２−ベンズヒドリル−１−アザビシクロ［２．２．２］オクト−３−イル）−（５−イソプロピル−２−メトキシベンジル）−アンモニウムクロリドの結晶多形
JP2012528849A (ja) * 2009-06-04 2012-11-15 ロッタファルム・ソシエタ・ペル・アチオニ ６−（１ｈ−イミダゾール−１−イル）−２−フェニルキナゾリンおよびその塩の結晶形
WO2016159268A1 (ja) * 2015-03-31 2016-10-06 有機合成薬品工業株式会社 潮解性を有さない３－アミノキヌクリジンの酸付加塩
JP2018525441A (ja) * 2015-08-04 2018-09-06 イッサム リサーチ ディベロップメンット カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド ピラゾールピリミジン誘導体及びその使用
JP2020511551A (ja) * 2017-03-21 2020-04-16 ビオプロジェ・ファルマ Ｈ３−リガンドの新たな治療用途

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637809A (en) 1968-07-05 1972-01-25 Ciba Geigy Corp Antioxidants
US3698123A (en) 1971-12-06 1972-10-17 Carl R Heldt Structural toys
US3917899A (en) 1972-08-04 1975-11-04 Michael J Oliver Plate for adjustably mounting electrical receptacle
US3846770A (en) 1973-07-11 1974-11-05 Us Navy Serial access memory using magnetic domains in thin film strips
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
DE2839461C2 (de) 1978-09-11 1987-01-15 Bergwerksverband Gmbh, 4300 Essen Formmassen aus thermoplastischen Kunststoffen und Rückständen der Kohlehydrierung
US4328246A (en) 1979-08-14 1982-05-04 Joseph Gold Anti Walker 256 carcinoma agent and combination thereof
US4409239A (en) 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US5762756A (en) 1994-11-21 1998-06-09 The Black Clawson Company Methods and apparatus for pulping and deinking
US6069696A (en) 1995-06-08 2000-05-30 Psc Scanning, Inc. Object recognition system and method
US6576139B1 (en) 1996-07-30 2003-06-10 Kenneth C. Hou Process for purifying photoresist composition employing a filter sheet
DE19630939C1 (de) 1996-07-31 1997-12-11 Siemens Ag Kontaktfeder
KR100218318B1 (ko) 1996-10-01 1999-09-01 문정환 주파수 변환장치
US7274662B1 (en) 1998-08-04 2007-09-25 At&T Corp. Method for performing segmented resource reservation
US6062668A (en) 1996-12-12 2000-05-16 Hitachi Koki Imaging Solutions, Inc. Drop detector for ink jet apparatus
US6364667B1 (en) 1997-03-14 2002-04-02 Relational Technologies Llp Techniques for mastering a body of knowledge by writing questions about the body of knowledge
US6073643A (en) 1998-09-14 2000-06-13 Patent Category Corp. Adjustable collapsible panels
DE20019821U1 (de) 1999-12-09 2001-06-07 BRAND GMBH + CO KG, 97877 Wertheim Dosiereinrichtung für Flüssigkeiten
JP2003520658A (ja) 2000-01-27 2003-07-08 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ 脊柱の幾何学的データを抽出する方法及びシステム
AU782084B2 (en) 2000-08-15 2005-06-30 Baker Hughes Incorporated Self lubricating swage
AP2001002264A0 (en) 2000-08-30 2001-09-30 Pfizer Prod Inc Sustained release formulations for growth hormone secretagogues.
MXPA03002200A (es) 2000-09-13 2007-10-02 Interdigital Tech Corp Intercalador de modem fdd de tercera generacion.
WO2002028911A2 (en) 2000-10-02 2002-04-11 The University Of Akron Synthesis and characterization of nanocomposites by emulsion polymerization
US7113943B2 (en) 2000-12-06 2006-09-26 Content Analyst Company, Llc Method for document comparison and selection
US7120761B2 (en) 2000-12-20 2006-10-10 Fujitsu Limited Multi-port memory based on DRAM core
JP4007767B2 (ja) 2001-01-18 2007-11-14 日本碍子株式会社 圧電／電歪デバイスおよびその製造方法
US6709874B2 (en) 2001-01-24 2004-03-23 Infineon Technologies Ag Method of manufacturing a metal cap layer for preventing damascene conductive lines from oxidation
US6980946B2 (en) 2001-03-15 2005-12-27 Microsoft Corporation Method for hybrid processing of software instructions of an emulated computer system
WO2002077657A1 (en) 2001-03-22 2002-10-03 Fujitsu Limited Magnetoresistive spin-valve sensor and magnetic storage apparatus
JP4124607B2 (ja) 2001-04-06 2008-07-23 ヤマウチ株式会社 ピンチローラおよびピンチローラ装置
US6840774B2 (en) 2001-05-07 2005-01-11 Jack W. Fretwell, Jr. System to teach, measure and rate learner knowledge of basic mathematics facts
US6798220B1 (en) 2001-06-27 2004-09-28 Timothy H. Flanigan Moisture/mold detector
US6891474B1 (en) 2001-08-01 2005-05-10 Tagsense, Inc. Electromagnetic identification label for anti-counterfeiting, authentication, and tamper-protection
US7345559B2 (en) 2001-09-13 2008-03-18 General Electric Company High field open MRI magnet isolation system and method
US6965468B2 (en) 2003-07-03 2005-11-15 Reflectivity, Inc Micromirror array having reduced gap between adjacent micromirrors of the micromirror array
US7039976B2 (en) 2002-04-09 2006-05-09 Maytag Corporation Braking control system for a washing machine
US6739477B1 (en) 2002-04-12 2004-05-25 Floro Pascual Golf ball dispenser
US7048737B2 (en) 2002-06-11 2006-05-23 Bioplate, Inc. Cranial bone flap fixation system and method
WO2004001741A1 (en) 2002-06-21 2003-12-31 Seagate Technology Llc Fluid dynamic bearing asymmetry pressure feedback
DE10240053A1 (de) 2002-08-30 2004-03-11 Robert Bosch Gmbh Brückenzünder-Zündelement
US6739108B2 (en) 2002-09-30 2004-05-25 Allpax Products, Inc. Fragile container handling system for retort/sterilization processes
JP2004158619A (ja) 2002-11-06 2004-06-03 Matsushita Electric Ind Co Ltd 電子デバイスおよびその製造方法
US6712069B1 (en) 2002-11-20 2004-03-30 William L. Spangler Solar energy collection and storage system
US7139876B2 (en) 2003-01-16 2006-11-21 Ip-First, Llc Microprocessor and apparatus for performing fast speculative pop operation from a stack memory cache
ITBO20030105A1 (it) 2003-02-28 2004-09-01 Fasco Spa Pistola pneumatica per elementi di fissaggio.
CN100425492C (zh) 2003-03-19 2008-10-15 日本精工株式会社 电动转向装置以及其中使用的树脂齿轮
US7248373B2 (en) 2003-03-21 2007-07-24 Durr Systems, Inc Workpiece configuration detection system and method
US6867376B2 (en) 2003-04-17 2005-03-15 Bellsouth Intellectual Property Corporation Glow rods with externally mountable anchoring members and related methods
US7069377B2 (en) 2003-05-08 2006-06-27 Micron Technology, Inc. Scratch control memory array in a flash memory device
FR2854693B1 (fr) 2003-05-09 2005-07-01 Siemens Vdo Automotive Procede de determination de l'energie d'un signal de cliquetis pour moteur a combustion interne
EP1658083B1 (en) 2003-06-19 2007-08-08 BODOR, Nicholas S. Enhancement of activity and/or duration of action of selected anti-inflammatory steroids
US6993866B1 (en) 2003-06-25 2006-02-07 James Strange Fishing bait rig attachment apparatus with rotating rattle
US6922367B2 (en) 2003-07-09 2005-07-26 Micron Technology, Inc. Data strobe synchronization circuit and method for double data rate, multi-bit writes
JP4183181B2 (ja) 2003-08-07 2008-11-19 株式会社小松製作所 異物除去装置
DE102004027446B4 (de) 2004-06-04 2007-08-23 Jungheinrich Aktiengesellschaft Vorrichtung zur Unterstützung des Ein- und Ausstapelns bei einem Stapler
US7197360B1 (en) 2005-01-12 2007-03-27 Pacesetter, Inc. Methods and systems for using an inductor to increase capacitor reformation efficiency in an implantable cardiac device (ICD)
US7377471B1 (en) 2005-06-06 2008-05-27 Compton Harry L Method and system for opening and securing a railroad frog
US7271369B2 (en) 2005-08-26 2007-09-18 Aem, Inc. Multilayer positive temperature coefficient device and method of making the same
JP4666514B2 (ja) 2006-07-20 2011-04-06 リンテック株式会社 シート剥離装置及び剥離方法
US7799600B2 (en) 2007-05-31 2010-09-21 Chien-Min Sung Doped diamond LED devices and associated methods
US7689648B2 (en) 2007-06-27 2010-03-30 Microsoft Corporation Dynamic peer network extension bridge
WO2019155468A1 (en) * 2018-02-08 2019-08-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Heteroaryl compounds, pharmaceutical compositions thereof, and their therapeutic use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003502425A (ja) * 1999-06-22 2003-01-21 ファイザー・プロダクツ・インク Ｎｋ−１受容体アンタゴニストとしての（２−ベンズヒドリル−１−アザビシクロ［２．２．２］オクト−３−イル）−（５−イソプロピル−２−メトキシベンジル）−アンモニウムクロリドの結晶多形
JP2012528849A (ja) * 2009-06-04 2012-11-15 ロッタファルム・ソシエタ・ペル・アチオニ ６−（１ｈ−イミダゾール−１−イル）−２−フェニルキナゾリンおよびその塩の結晶形
WO2016159268A1 (ja) * 2015-03-31 2016-10-06 有機合成薬品工業株式会社 潮解性を有さない３－アミノキヌクリジンの酸付加塩
JP2018525441A (ja) * 2015-08-04 2018-09-06 イッサム リサーチ ディベロップメンット カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム リミテッド ピラゾールピリミジン誘導体及びその使用
JP2020511551A (ja) * 2017-03-21 2020-04-16 ビオプロジェ・ファルマ Ｈ３−リガンドの新たな治療用途

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CELL, vol. 175, no. 1, JPN6024019481, 23 August 2018 (2018-08-23), pages 171 - 185, ISSN: 0005329354 *

Also Published As

Publication number Publication date
TW202110827A (zh) 2021-03-16
SG11202113211PA (en) 2021-12-30
MX2021014842A (es) 2022-02-21
EP3976600A1 (en) 2022-04-06
IL288547A (en) 2022-02-01
IL288547B2 (en) 2025-10-01
KR20220041050A (ko) 2022-03-31
TWI866977B (zh) 2024-12-21
US12428399B2 (en) 2025-09-30
CA3142271A1 (en) 2020-12-10
US20220332702A1 (en) 2022-10-20
BR112021024330A2 (pt) 2022-01-11
WO2020247345A1 (en) 2020-12-10
IL288547B1 (en) 2025-06-01
CN114423752B (zh) 2025-06-24
AU2020288163A1 (en) 2022-01-06
CN114423752A (zh) 2022-04-29
AU2020288163B2 (en) 2026-03-26

Similar Documents

Publication Publication Date Title
JP7258924B2 (ja) ブルトンチロシンキナーゼの阻害剤を含む剤形組成物
JP7073316B2 (ja) 癌の治療のためのｅｒｂｂチロシンキナーゼ阻害剤としてのベンゾイミダゾール誘導体
JP2024107365A (ja) バルベナジン塩およびその多形体
JP2022535850A (ja) ピラゾール化合物の非吸湿性結晶塩、ならびにその医薬組成物および使用
EP3515414B1 (en) Combination therapy
JP2023022081A (ja) 併用療法
TW201305143A (zh) 光學活性吡唑基胺基喹唑啉及其醫藥組合物及使用方法
AU2017356926A1 (en) Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use
US20240226101A1 (en) Pyrimidinylaminobenzenes for lung cancer treatment
KR20160061322A (ko) 3,5-디아미노피라졸 키나아제 억제제의 약제학적으로 허용가능한 염
CN103270030B (zh) 吡唑基氨基喹唑啉的氢溴酸盐

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230601

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230601

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240821

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241021

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20241030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20241030

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241121

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250115

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250515